SPRYCEL vs VUMON

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. SPRYCEL and VUMON are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	SPRYCEL	VUMON
Rating	72/100	New
Pharmacy pays	~$839.19 /30	—
Type	RX	RX
Active ingredient	DASATINIB	TENIPOSIDE
Manufacturer	Bristol Myers Squibb	Hq Speclt Pharma
Dosage forms	Tablet	Injectable
Drug class	Kinase Inhibitor	—
Boxed warning	None	None
Treats	Lymphoid Leukemia, Myeloid Leukemia	Lymphoid Leukemia, Lung Neoplasms, Small Cell Carcinoma

sprycel vumon

Rating

72/100

New

Pharmacy pays

~$839.19 /30

—

Type

Active ingredient

DASATINIB

TENIPOSIDE

Manufacturer

Bristol Myers Squibb

Hq Speclt Pharma

Dosage forms

Tablet

Injectable

Drug class

Kinase Inhibitor

—

Boxed warning

None

Treats

Lymphoid Leukemia, Myeloid Leukemia

Lymphoid Leukemia, Lung Neoplasms, Small Cell Carcinoma

Frequently asked questions

What is the difference between Sprycel and Vumon?

Sprycel contains Dasatinib, while Vumon contains Teniposide — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.